Purification of baculovirus vectors using heparin affinity chromatography

Molecular Therapy Methods and Clinical Development

Volumn 3, Issue , 2016, Pages 16071-

  Nasimuzzaman, Md ^a,b   Lynn, Danielle ^a   van der Loo, Johannes CM ^a,b   Malik, Punam ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACULOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; HEPARIN; HEPARAN SULFATE;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; BACULOVIRIDAE; DNA VIRUS INFECTION; HUMAN; HUMAN CELL; MOLECULAR SIZE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; SCALE UP; SPODOPTERA FRUGIPERDA; SUPERNATANT; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; CELL POPULATION; CYTOTOXICITY; FLUORESCENCE MICROSCOPE; FLUORESCENCE MICROSCOPY; IMMUNOBLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; SF9 CELL LINE; SILVER STAINING; TRANSIENT TRANSFECTION; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; VIRUS PURIFICATION;

EID: 85015222217     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2016.71     Document Type: Article

References (37)

1. 1 Ikonomou, L, Schneider, YJ, Agathos, SN, Insect cell culture for industrial production of recombinant proteins. Appl Microbiol Biotechnol 62 (2003), 1–20.
2. 2 Contreras-Gómez, A, Sánchez-Mirón, A, García-Camacho, F, Molina-Grima, E, Chisti, Y, Protein production using the baculovirus-insect cell expression system. Biotechnol Prog 30 (2014), 1–18.
3. 3 Cox, MM, Recombinant protein vaccines produced in insect cells. Vaccine 30 (2012), 1759–1766.
4. 4 Boyce, FM, Bucher, NL, Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 93 (1996), 2348–2352.
5. 5 Kost, TA, Condreay, JP, Jarvis, DL, Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23 (2005), 567–575.
6. 6 Heimpel, AM, Buchanan, LK, Human feeding tests using a nuclear-polyhedrosis virus of Heliothis zea. J Invertebr Pathol 9 (1967), 55–57.
7. 7 Hu, YC, Baculoviral vectors for gene delivery: a review. Curr Gene Ther 8 (2008), 54–65.
8. 8 Airenne, KJ, Hu, YC, Kost, TA, Smith, RH, Kotin, RM, Ono, C, et al. Baculovirus: an insect-derived vector for diverse gene transfer applications. Mol Ther 21 (2013), 739–749.
9. 9 Kenoutis, C, Efrose, RC, Swevers, L, Lavdas, AA, Gaitanou, M, Matsas, R, et al. Baculovirus-mediated gene delivery into Mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression. J Virol 80 (2006), 4135–4146.
10. 10 Makkonen, KE, Airenne, K, Ylä-Herttulala, S, Baculovirus-mediated gene delivery and RNAi applications. Viruses 7 (2015), 2099–2125.
11. 11 Blissard, GW, Rohrmann, GF, Baculovirus diversity and molecular biology. Annu Rev Entomol 35 (1990), 127–155.
12. 12 Zeng, J, Du, J, Zhao, Y, Palanisamy, N, Wang, S, Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 25 (2007), 1055–1061.
13. 13 Zeng, J, Du, J, Lin, J, Bak, XY, Wu, C, Wang, S, High-efficiency transient transduction of human embryonic stem cell-derived neurons with baculoviral vectors. Mol Ther 17 (2009), 1585–1593.
14. 14 Sung, LY, Chen, CL, Lin, SY, Li, KC, Yeh, CL, Chen, GY, et al. Efficient gene delivery into cell lines and stem cells using baculovirus. Nat Protoc 9 (2014), 1882–1899.
15. 15 Chen, CY, Lin, CY, Chen, GY, Hu, YC, Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv 29 (2011), 618–631.
16. 16 Stanbridge, LJ, Dussupt, V, Maitland, NJ, Baculoviruses as vectors for gene therapy against human prostate cancer. J Biomed Biotechnol 2003 (2003), 79–91.
17. 17 Kim, YK, Kwon, JT, Choi, JY, Jiang, HL, Arote, R, Jere, D, et al. Suppression of tumor growth in xenograft model mice by programmed cell death 4 gene delivery using folate-PEG-baculovirus. Cancer Gene Ther 17 (2010), 751–760.
18. 18 Cecchini, S, Virag, T, Kotin, RM, Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02- to 200-liter cultures. Hum Gene Ther 22 (2011), 1021–1030.
19. 19 Allay, JA, Sleep, S, Long, S, Tillman, DM, Clark, R, Carney, G, et al. Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial. Hum Gene Ther 22 (2011), 595–604.
20. 20 Merten, OW, Charrier, S, Laroudie, N, Fauchille, S, Dugué, C, Jenny, C, et al. Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application. Hum Gene Ther 22 (2011), 343–356.
21. 21 Makkonen, KE, Turkki, P, Laakkonen, JP, Ylä-Herttuala, S, Marjomäki, V, Airenne, KJ, 6-o- and N-sulfated syndecan-1 promotes baculovirus binding and entry into Mammalian cells. J Virol 87 (2013), 11148–11159.
22. 22 Nasimuzzaman, M, Heparan sulfate in baculovirus binding and entry of mammalian cells. J Virol 88 (2014), 4607–4608.
23. 23 Nasimuzzaman, M, Persons, DA, Cell membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells. Mol Ther 20 (2012), 1158–1166.
24. 24 Nasimuzzaman, M, Lynn, D, Ernst, R, Beuerlein, R, Smith, RH, Shrestha, A, et al. Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency. Mol Ther Methods Clin Dev, 1, 2015, 14020.
25. 25 Urabe, M, Nakakura, T, Xin, KQ, Obara, Y, Mizukami, H, Kume, A, et al. Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J Virol 80 (2006), 1874–1885.
26. 26 Wu, C, Wang, S, A pH-sensitive heparin-binding sequence from Baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9 insect cells. J Virol 86 (2012), 484–491.
27. 27 Wu, C, Soh, KY, Wang, S, Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum Gene Ther 18 (2007), 665–672.
28. 28 Bess, JW Jr, Gorelick, RJ, Bosche, WJ, Henderson, LE, Arthur, LO, Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virol 230 (1997), 134–144.
29. 29 Michalsky, R, Passarelli, AL, Pfromm, PH, Czermak, P, Concentration of the baculovirus autographa californica M nucleopolyhedrovirus (AcMNPV) by ultrafiltration. Desalination 250 (2010), 1125–1127.
30. 30 Vicente, T, Peixoto, C, Carrondo, MJ, Alves, PM, Purification of recombinant baculoviruses for gene therapy using membrane processes. Gene Ther 16 (2009), 766–775.
31. 31 Eaves, GN, Jeffries, CD, Isolation and properties of an exocellular nuclease of serratia marcescens. J Bacteriol 85 (1963), 273–278.
32. 32 Jorio, H, Tran, R, Meghrous, J, Bourget, L, Kamen, A, Analysis of baculovirus aggregates using flow cytometry. J Virol Methods 134 (2006), 8–14.
33. 33 Floyd, R, Sharp, DG, Viral aggregation: buffer effects in the aggregation of poliovirus and reovirus at low and high pH. Appl Environ Microbiol 38 (1979), 395–401.
34. 34 Whitney, D, McCoy, M, Gordon, N, Afeyan, N, Characterization of large-pore polymeric supports for use in perfusion biochromatography. J Chromatogr A 807 (1998), 165–184.
35. 35 Chalabi, N, Maurizis, JC, Le Corre, L, Delort, L, Bignon, YJ, Bernard-Gallon, DJ, Quantification by affinity perfusion chromatography of phosphorylated BRCAl and BRCA2 proteins from tumor cells after lycopene treatment. J Chromatogr B Analyt Technol Biomed Life Sci 821 (2005), 188–193.
36. 36 Nasimuzzaman, M, Waris, G, Mikolon, D, Stupack, DG, Siddiqui, A, Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J Virol 81 (2007), 10249–10257.
37. 37 Nasimuzzaman, M, Kuroda, M, Dohno, S, Yamamoto, T, Iwatsuki, K, Matsuzaki, S, et al. Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1. Mol Ther 11 (2005), 578–590.